ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found”

May 3, 1985

Researchers Identify Subtype Demonstrating Angiogenesis

February 24, 2012

Vanderbilt physician-scientist Philip Browning, 51, dead of colon cancer.

June 25, 2004

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

Study: Lack of Sleep Linked With Agressive Breast Cancers

September 28, 2012